Status:
COMPLETED
Risk Factors and the Role of Albumin-to-globulin Ratio in Idiopathic Granulomatous Mastitis
Lead Sponsor:
Samsun Education and Research Hospital
Conditions:
Idiopathic Granulomatous Mastitis
Eligibility:
FEMALE
18+ years
Brief Summary
Albumin-to-globulin ratio (AGR) is an inflammation-based index that has been shown to have a role in many cancers and inflammatory diseases. Idiopathic granulomatous mastitis (IGM) is a rare inflammat...
Detailed Description
Patients diagnosed with IGM on pathology reports between January 2016 and March 2021 were enrolled in the study and their medical records were analyzed retrospectively. The patients were divided into ...
Eligibility Criteria
Inclusion
- The patients with a pathologically confirmed diagnosis of granulomatous mastitis
- Patients over the age of 18
- Female patients
Exclusion
- Male patients
- Secondary granulomatous mastitis etiologies (tuberculous mastitis and Wegener's granulomatosis)
- Patients who do not have enough follow-up information
- Patients with missing data
Key Trial Info
Start Date :
April 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 25 2022
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT05409586
Start Date
April 20 2022
End Date
May 25 2022
Last Update
June 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsun Eğitim ve Araştırma Hastanesi
Samsun, Turkey (Türkiye), 55090